Skip to content

Effect of Individualized Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Disorder of Consciousness

Effect of Individualized Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Disorder of Consciousness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055592
Enrollment
Unknown
Registered
2022-01-14
Start date
2021-06-09
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of consciousness

Interventions

group 1:phase I: rTMS-active
phase II: rTMS-sham
group 2:phase I: rTMS-sham
phase II: rTMS-active

Sponsors

Department of Rehabilitation,Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Acquired brain injuries less than 1 year and more than 28 days in DOC; 2.No medical history of neuropsychiatric diseases; 3.No contraindications for rTMS or EEG, no sedatives in use or other drugs that might interfere with brain stimulation, such as Na+ or Ca2+ channel blockers or NMDA receptor antagonists; 4.Stable state of disease and vital signs; 5.The families of the patients volunteered the patient to participate in the study and provided signed informed consent; 6.The integrity of the individualized stimulation target cortex are verified by MRI.Exclusion criteria.

Exclusion criteria

Exclusion criteria: 1.Patients in other non-invasive or invasive neuroregulation trials; 2.Motor evoked potential (MEP) in M1 region cannot be induced by TMS pulse; 3.Uncontrolled epilepsy, seizure within 4 weeks before enrollment; 4.Metallic implant in the skull, pacemaker, craniotomy under the stimulated site, implanted brain device.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale Revised;

Secondary

MeasureTime frame
Relative power spectral of rest-EEG;functional connectivity of rest-EEG;TMS evoked potential;global mean field amplitude;To evaluate the safety of rTMS in DoC patients.;

Countries

China

Contacts

Public ContactQiuyou Xie

Zhujiang Hospital of Southern Medical University

764942251@qq.com+86 13903019604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026